Carcinoma, Non-Small-Cell Lung
"Carcinoma, Non-Small-Cell Lung" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
MeSH Number(s)
C04.588.894.797.520.109.220.249
C08.381.540.140.500
C08.785.520.100.220.500
Concept/Terms
Carcinoma, Non-Small-Cell Lung- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Non Small Cell Lung
- Carcinomas, Non-Small-Cell Lung
- Lung Carcinoma, Non-Small-Cell
- Lung Carcinomas, Non-Small-Cell
- Non-Small-Cell Lung Carcinomas
- Non-Small Cell Lung Cancer
- Non-Small-Cell Lung Carcinoma
- Non Small Cell Lung Carcinoma
- Carcinoma, Non-Small Cell Lung
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Non-Small-Cell Lung".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Non-Small-Cell Lung".
This graph shows the total number of publications written about "Carcinoma, Non-Small-Cell Lung" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Non-Small-Cell Lung" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 6 | 2 | 8 |
| 1992 | 6 | 0 | 6 |
| 1993 | 7 | 0 | 7 |
| 1994 | 15 | 4 | 19 |
| 1995 | 20 | 5 | 25 |
| 1996 | 15 | 3 | 18 |
| 1997 | 9 | 5 | 14 |
| 1998 | 18 | 1 | 19 |
| 1999 | 13 | 2 | 15 |
| 2000 | 12 | 3 | 15 |
| 2001 | 26 | 5 | 31 |
| 2002 | 18 | 4 | 22 |
| 2003 | 26 | 4 | 30 |
| 2004 | 32 | 4 | 36 |
| 2005 | 65 | 6 | 71 |
| 2006 | 47 | 13 | 60 |
| 2007 | 52 | 9 | 61 |
| 2008 | 71 | 7 | 78 |
| 2009 | 64 | 8 | 72 |
| 2010 | 82 | 7 | 89 |
| 2011 | 88 | 9 | 97 |
| 2012 | 84 | 14 | 98 |
| 2013 | 93 | 11 | 104 |
| 2014 | 114 | 17 | 131 |
| 2015 | 147 | 13 | 160 |
| 2016 | 136 | 20 | 156 |
| 2017 | 119 | 12 | 131 |
| 2018 | 158 | 9 | 167 |
| 2019 | 159 | 9 | 168 |
| 2020 | 126 | 10 | 136 |
| 2021 | 56 | 2 | 58 |
Below are the most recent publications written about "Carcinoma, Non-Small-Cell Lung" by people in Profiles.
-
The Nordic-HILUS Trial: Ultracentral Lung Stereotactic Ablative Radiotherapy and a Narrow Therapeutic Window. J Thorac Oncol. 2021 10; 16(10):e79-e80.
-
Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice. Nat Commun. 2021 09 28; 12(1):5680.
-
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma. ESMO Open. 2021 10; 6(5):100253.
-
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer. ESMO Open. 2021 10; 6(5):100254.
-
Hype or hope - Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC? Crit Rev Oncol Hematol. 2021 Oct; 166:103454.
-
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy. Ann Oncol. 2021 11; 32(11):1391-1399.
-
The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLC. Lung Cancer. 2021 10; 160:118-126.
-
Immunotherapy in Patients With Poor Performance Status: The Jury Is Still Out on This Special Population. JCO Oncol Pract. 2021 09; 17(9):583-586.
-
Lung cancer. Lancet. 2021 08 07; 398(10299):535-554.
-
Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer. Lung Cancer. 2021 09; 159:56-65.